| Antigen | 28-aa peptide of Human D2R ; Designated (D2R13-P or control peptide /blocking peptide) conjugated to KLH.
Epitope location. ~ N-terminal, Cytoplasmic |
| Form | Antigen/blocking Peptide |
| Product Type | Peptide |
| SpCrossreactivity | Human D2R13-P peptide was specific for D2R. No significant sequence homology is seen with other dopamine receptors (D1 and D3-D5). It is 100% homologous with human/bovine/dog, and 50% with Xenopus D2 receptors. Antibodies generated to the human sequence have been shown to recognize the canine D2R (2). Antibody crossreactivity with D2 receptors from various species is not known. |
| SpeciesReactivity | Human |
| SugApplications | Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. |